Related Experiment Video
Updated: Jun 20, 2026

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
Endovascular repair of the thoracic aorta
Joshua D Adams1, Lleowell M Garcia, John A Kern
1Department of Radiology, University of Virginia Health System, PO Box 800170, Charlottesville, VA 22908, USA.
Insights
Endovascular stent grafts offer a minimally invasive option for descending thoracic aorta conditions. Careful planning and patient selection are key to successful outcomes with these devices.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Interventional Radiology
Background:
- Descending thoracic aorta pathologies, including aneurysms, traumatic injuries, and dissections, pose significant clinical challenges.
- Traditional open surgical repair carries substantial risks, driving the need for less invasive alternatives.
Purpose of the Study:
- To review the current applications and outcomes of endovascular stent grafts for descending thoracic aorta treatment.
- To highlight the role of patient selection and case planning in endovascular aortic repair.
Main Methods:
- Review of current literature and FDA-approved endovascular stent graft devices for descending thoracic aorta conditions.
- Discussion of ongoing studies investigating endovascular treatment for traumatic aortic injury and Stanford type B dissection.
Main Results:
- Three endovascular stent graft devices are currently FDA-approved for descending thoracic aneurysms.
- Ongoing research is exploring the efficacy of endovascular treatments for complex aortic pathologies.
Conclusions:
- Endovascular stent grafting is a viable treatment modality for descending thoracic aorta diseases.
- Optimal outcomes are contingent upon meticulous pre-procedural planning and judicious patient selection.
- Advancements in device technology and delivery systems are expected to further enhance treatment efficacy.
Abstract:
The use of endovascular stent grafts for treatment of the descending thoracic aorta is reviewed. Currently, 3 devices have been approved by the US Food and Drug Administration for the treatment of descending thoracic aneurysms, and multiple studies are ongoing to investigate the efficacy of endovascular treatment in such pathologies as traumatic aortic injury and Stanford type B dissection. Outcomes are highly dependent on good case planning and patient selection and will likely continue to improve as newer-generation devices and delivery systems are designed and made available.
Related Concept Videos
Aneurysm III: Interprofessional Care
Thoracic Aorta
